Literature DB >> 14207891

DIFFERENTIAL DIAGNOSIS OF CUSHING'S SYNDROME AND OBESITY ASSOCIATED WITH STRIAE.

V K SUMMERS, H L SHEEHAN, L J HIPKIN, J C DAVIS.   

Abstract

Entities:  

Keywords:  17-HYDROXYCORTICOSTEROIDS; 17-KETOSTEROIDS; ALDOSTERONE ANTAGONISTS; BETAMETHASONE; CORTICOTROPIN; CUSHING'S SYNDROME; DIAGNOSIS, DIFFERENTIAL; EXCRETION; HYPERTRICHOSIS; KETONES; METABOLISM; METYRAPONE; OBESITY; PITUITARY-ADRENAL FUNCTION TESTS; URINE

Mesh：

Substances：

Year:  1964        PMID： 14207891     DOI： 10.1016/s0140-6736(64)92606-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  CHLORPHENTERMINE S.A. IN THE TREATMENT OF OBESITY AND THE EFFECT OF WEIGHT LOSS ON STEROID EXCRETION.

Authors:  I M JACKSON; W G WHYTE
Journal:  Br Med J       Date:  1965-08-21

2.  Plasma and urinary 11-hydroxycorticosteroids in differential diagnosis of Cushing's syndrome.

Authors:  D Mattingly; C Tyler
Journal:  Br Med J       Date:  1972-07-01

3.  [The diagnosis and differential diagnosis of Cushing's syndrome by means of an abbreviated dexamethasone test in the determination of corticosteroids in plasma].

Authors:  H Bethge; M T Brauns; H G Solbach; W Winkelmann; H Zimmermann
Journal:  Klin Wochenschr       Date:  1966-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.